Viewing Study NCT03443960


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 12:27 AM
Study NCT ID: NCT03443960
Status: COMPLETED
Last Update Posted: 2018-04-24
First Post: 2018-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules
Sponsor: Tonix Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module